ALASTAIR THOMPSON to Carcinoma
This is a "connection" page, showing publications ALASTAIR THOMPSON has written about Carcinoma.
Connection Strength
0.423
-
HER2 assessment on core biopsy specimens using monoclonal antibody CB11 accurately determines HER2 status in breast carcinoma. Histopathology. 2010 May; 56(6):702-7.
Score: 0.157
-
Expression of the Hypermethylated in Cancer gene (HIC-1) is associated with good outcome in human breast cancer. Br J Cancer. 2001 Dec 14; 85(12):1878-82.
Score: 0.088
-
Comparison of mammographic findings after intraoperative radiotherapy or external beam whole breast radiotherapy. Eur J Surg Oncol. 2014 Feb; 40(2):163-7.
Score: 0.050
-
Polo Like Kinase 2 Tumour Suppressor and cancer biomarker: new perspectives on drug sensitivity/resistance in ovarian cancer. Oncotarget. 2012 Jan; 3(1):78-83.
Score: 0.044
-
The prolyl 3-hydroxylases P3H2 and P3H3 are novel targets for epigenetic silencing in breast cancer. Br J Cancer. 2009 May 19; 100(10):1687-96.
Score: 0.037
-
A candidate molecular signature associated with tamoxifen failure in primary breast cancer. Breast Cancer Res. 2008; 10(5):R88.
Score: 0.035
-
Evidence implicating at least two genes on chromosome 17p in breast carcinogenesis. Lancet. 1990 Sep 29; 336(8718):761-3.
Score: 0.010
-
Telomere reduction in human colorectal carcinoma and with ageing. Nature. 1990 Aug 30; 346(6287):866-8.
Score: 0.003